Literature DB >> 19218333

Impact of exercise training on myostatin expression in the myocardium and skeletal muscle in a chronic heart failure model.

Karsten Lenk1, Robert Schur, Axel Linke, Sandra Erbs, Yasuharu Matsumoto, Volker Adams, Gerhard Schuler.   

Abstract

AIMS: In late-stage chronic heart failure (CHF), elevated cytokines and cachexia are often observed. Several studies have shown that exercise training exerts beneficial effects on skeletal muscle in this setting. Furthermore, it has been shown that the expression of myostatin, a key regulator of skeletal muscle mass, is increased in a variety of cachectic states. This study aimed to investigate the expression of myostatin in CHF, the influence of exercise training on myostatin levels, and regulation of myostatin by tumour necrosis factor-alpha (TNF-alpha). METHODS AND
RESULTS: In an animal model of CHF (LAD-ligation model), protein expression of myostatin was elevated 2.4-fold in the skeletal muscle and more than four-times in the myocardium, compared with control (Co). Exercise training on a treadmill over 4 weeks led to a significant reduction in myostatin protein expression in the skeletal muscle and the myocardium of CHF animals, with values returning to baseline levels. In differentiated C2C12 cells, TNF-alpha induced the expression of myostatin through a p38MAPK-dependent pathway involving nuclear factor kappa-B (NF-kappaB). The increased TNF-alpha mRNA levels in the skeletal muscle of CHF animals correlated significantly with myostatin expression.
CONCLUSION: These alterations in myostatin expression in the skeletal and heart muscle following exercise training could help to explain the beneficial anti-catabolic effects of exercise training in CHF.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19218333     DOI: 10.1093/eurjhf/hfp020

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  42 in total

Review 1.  Targeting Age-Related Pathways in Heart Failure.

Authors:  Haobo Li; Margaret H Hastings; James Rhee; Lena E Trager; Jason D Roh; Anthony Rosenzweig
Journal:  Circ Res       Date:  2020-02-13       Impact factor: 17.367

Review 2.  Exercise in Heart Failure-What Is the Optimal Dose to Improve Pathophysiology and Exercise Capacity?

Authors:  Michael Johannes Schindler; Volker Adams; Martin Halle
Journal:  Curr Heart Fail Rep       Date:  2019-08

3.  Increased circulating myostatin in patients with type 2 diabetes mellitus.

Authors:  Fang Wang; Yonggan Liao; Xuefeng Li; Chunlin Ren; Changming Cheng; Yongsheng Ren
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-08-11

Review 4.  Skeletal muscle alterations in HFrEF vs. HFpEF.

Authors:  Volker Adams; Axel Linke; Ephraim Winzer
Journal:  Curr Heart Fail Rep       Date:  2017-12

Review 5.  Anabolism to Catabolism: Serologic Clues to Nutritional Status in Heart Failure.

Authors:  Laura Murphy; Alastair Gray; Emer Joyce
Journal:  Curr Heart Fail Rep       Date:  2019-10

Review 6.  Expression and function of myostatin in obesity, diabetes, and exercise adaptation.

Authors:  David L Allen; Dustin S Hittel; Alexandra C McPherron
Journal:  Med Sci Sports Exerc       Date:  2011-10       Impact factor: 5.411

7.  Myostatin and follistatin expression in skeletal muscles of rats with chronic heart failure.

Authors:  Aline Regina Ruiz Lima; Paula Felippe Martinez; Katashi Okoshi; Daniele Mendes Guizoni; Leonardo A Mamede Zornoff; Dijon Henrique Salomé Campos; Sílvio Assis Oliveira; Camila Bonomo; Maeli Dal Pai-Silva; Marina Politi Okoshi
Journal:  Int J Exp Pathol       Date:  2009-12-03       Impact factor: 1.925

Review 8.  Skeletal muscle protein metabolism in human heart failure.

Authors:  Damien M Callahan; Michael J Toth
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2013-01       Impact factor: 4.294

Review 9.  Cachexia in chronic heart failure: endocrine determinants and treatment perspectives.

Authors:  Norman Mangner; Yae Matsuo; Gerhard Schuler; Volker Adams
Journal:  Endocrine       Date:  2012-08-19       Impact factor: 3.633

10.  Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition.

Authors:  Fabio Penna; Domiziana Costamagna; Alessandro Fanzani; Gabriella Bonelli; Francesco M Baccino; Paola Costelli
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.